학술논문
Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial
Document Type
Article
Author
Source
In The Lancet Infectious Diseases August 2021 21(8):1151-1160
Subject
Language
ISSN
1473-3099